Success Metrics

Clinical Success Rate
96.3%

Based on 26 completed trials

Completion Rate
96%(26/27)
Active Trials
1(3%)
Results Posted
0%(0 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_2
12
38%
Ph phase_1
1
3%
Ph phase_3
19
59%

Phase Distribution

1

Early Stage

12

Mid Stage

19

Late Stage

Phase Distribution32 total trials
Phase 1Safety & dosage
1(3.1%)
Phase 2Efficacy & side effects
12(37.5%)
Phase 3Large-scale testing
19(59.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

96.3%

26 of 27 finished

Non-Completion Rate

3.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

32

all time

Status Distribution
Active(1)
Completed(26)
Terminated(1)
Other(4)

Detailed Status

Completed26
unknown4
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
32
Active
1
Success Rate
96.3%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (3.1%)
Phase 212 (37.5%)
Phase 319 (59.4%)

Trials by Status

active_not_recruiting13%
terminated13%
unknown413%
completed2681%

Recent Activity

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT00002462Phase 3

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

Active Not Recruiting
NCT00002654Phase 3

Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer

Completed
NCT00002865Phase 2

High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

Completed
NCT00002744Phase 3

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia

Completed
NCT00002676Phase 2

Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma

Completed
NCT00002494Phase 2

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Completed
NCT00002735Phase 2

SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue

Terminated
NCT00002804Phase 2

Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma

Completed
NCT00002740Phase 1

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma

Completed
NCT00002785Phase 2

Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia

Completed
NCT00002805Phase 2

Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Completed
NCT00002618Phase 3

Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma

Completed
NCT00767286Phase 3

Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Completed
NCT00771641Phase 3

Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck

Completed
NCT00002670Phase 3

Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery

Completed
NCT00002496Phase 3

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx

Completed
NCT00002599Phase 3

Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma

Unknown
NCT00002802Phase 3

Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma

Completed
NCT00002755Phase 3

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Completed
NCT00002747Phase 3

Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer

Unknown

Drug Details

Intervention Type
RADIATION
Total Trials
32